Fluorescence-assisted cytological testing (FACT): Ex vivo viral method for enhancing detection of rare cancer cells in body fluids

Prasad S. Adusumilli, Sepideh Gholami, Yun Shin Chun, Michael Mullerad, Mei Ki Chan, Zhenkun Yu, Leah Ben-Porat, Valerie W. Rusch, Yuman Fong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cytological analysis of body fluids is currently used for detecting cancer. The objective of this study was to determine if the herpes virus carrying an enhanced green fluorescent protein (EGFP) could detect rare cancer cells in body fluids against millions of normal cells. Human cancer cells suspended with normal murine cells were infected with NV1066 at a multiplicity of infection (MOI) of 0.5 and 1.0 for 18 h. Fluorescent microscopy and flow cytometry were used for EGFP detection of cancer cells. EGFP-expressing cells were confirmed as cancer cells with specific markers by immunohistochemistry staining. Limits of detection of cancer cells in body fluid were measured by serial dilutions. Applicability of technique was confirmed with samples from patients with malignant pleural effusions. NV1066 expressed EGFP in 111 human cancer cell lines detected by fluorescent microscopy at an MOI of 0.5. NV1066 selectively infected cancer cells and spared normal cells as confirmed by immunohistochemistry. Sensitivity of detecting fluorescent green cells was 92% (confidence interval [CI] 83% to 97%) at a ratio of 1 cancer cell to 1 million normal cells. EGFP-positive cells were detected by fluorescent microscopy in patients' malignant pleural effusion samples. Our data show proof of the concept that NV1066-induced EGFP expression allows detection of a single cancer cell against a background of 1 million normal cells. This method was demonstrated to be a reliable screening tool for human cancer cells in a suspension of norma murine cells as well as clinical specimens of malignant pleural effusions.

Original languageEnglish (US)
Pages (from-to)628-634
Number of pages7
JournalMolecular Medicine
Volume17
Issue number7-8
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Body Fluids
Fluorescence
Neoplasms
Malignant Pleural Effusion
Microscopy
Cell Body
Immunohistochemistry
Infection
Limit of Detection
enhanced green fluorescent protein

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Fluorescence-assisted cytological testing (FACT) : Ex vivo viral method for enhancing detection of rare cancer cells in body fluids. / Adusumilli, Prasad S.; Gholami, Sepideh; Chun, Yun Shin; Mullerad, Michael; Chan, Mei Ki; Yu, Zhenkun; Ben-Porat, Leah; Rusch, Valerie W.; Fong, Yuman.

In: Molecular Medicine, Vol. 17, No. 7-8, 01.07.2011, p. 628-634.

Research output: Contribution to journalArticle

Adusumilli, Prasad S. ; Gholami, Sepideh ; Chun, Yun Shin ; Mullerad, Michael ; Chan, Mei Ki ; Yu, Zhenkun ; Ben-Porat, Leah ; Rusch, Valerie W. ; Fong, Yuman. / Fluorescence-assisted cytological testing (FACT) : Ex vivo viral method for enhancing detection of rare cancer cells in body fluids. In: Molecular Medicine. 2011 ; Vol. 17, No. 7-8. pp. 628-634.
@article{c21f951d50c74d6f8bf796d109e7866c,
title = "Fluorescence-assisted cytological testing (FACT): Ex vivo viral method for enhancing detection of rare cancer cells in body fluids",
abstract = "Cytological analysis of body fluids is currently used for detecting cancer. The objective of this study was to determine if the herpes virus carrying an enhanced green fluorescent protein (EGFP) could detect rare cancer cells in body fluids against millions of normal cells. Human cancer cells suspended with normal murine cells were infected with NV1066 at a multiplicity of infection (MOI) of 0.5 and 1.0 for 18 h. Fluorescent microscopy and flow cytometry were used for EGFP detection of cancer cells. EGFP-expressing cells were confirmed as cancer cells with specific markers by immunohistochemistry staining. Limits of detection of cancer cells in body fluid were measured by serial dilutions. Applicability of technique was confirmed with samples from patients with malignant pleural effusions. NV1066 expressed EGFP in 111 human cancer cell lines detected by fluorescent microscopy at an MOI of 0.5. NV1066 selectively infected cancer cells and spared normal cells as confirmed by immunohistochemistry. Sensitivity of detecting fluorescent green cells was 92{\%} (confidence interval [CI] 83{\%} to 97{\%}) at a ratio of 1 cancer cell to 1 million normal cells. EGFP-positive cells were detected by fluorescent microscopy in patients' malignant pleural effusion samples. Our data show proof of the concept that NV1066-induced EGFP expression allows detection of a single cancer cell against a background of 1 million normal cells. This method was demonstrated to be a reliable screening tool for human cancer cells in a suspension of norma murine cells as well as clinical specimens of malignant pleural effusions.",
author = "Adusumilli, {Prasad S.} and Sepideh Gholami and Chun, {Yun Shin} and Michael Mullerad and Chan, {Mei Ki} and Zhenkun Yu and Leah Ben-Porat and Rusch, {Valerie W.} and Yuman Fong",
year = "2011",
month = "7",
day = "1",
doi = "10.2119/molmed.2011.00078",
language = "English (US)",
volume = "17",
pages = "628--634",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "7-8",

}

TY - JOUR

T1 - Fluorescence-assisted cytological testing (FACT)

T2 - Ex vivo viral method for enhancing detection of rare cancer cells in body fluids

AU - Adusumilli, Prasad S.

AU - Gholami, Sepideh

AU - Chun, Yun Shin

AU - Mullerad, Michael

AU - Chan, Mei Ki

AU - Yu, Zhenkun

AU - Ben-Porat, Leah

AU - Rusch, Valerie W.

AU - Fong, Yuman

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Cytological analysis of body fluids is currently used for detecting cancer. The objective of this study was to determine if the herpes virus carrying an enhanced green fluorescent protein (EGFP) could detect rare cancer cells in body fluids against millions of normal cells. Human cancer cells suspended with normal murine cells were infected with NV1066 at a multiplicity of infection (MOI) of 0.5 and 1.0 for 18 h. Fluorescent microscopy and flow cytometry were used for EGFP detection of cancer cells. EGFP-expressing cells were confirmed as cancer cells with specific markers by immunohistochemistry staining. Limits of detection of cancer cells in body fluid were measured by serial dilutions. Applicability of technique was confirmed with samples from patients with malignant pleural effusions. NV1066 expressed EGFP in 111 human cancer cell lines detected by fluorescent microscopy at an MOI of 0.5. NV1066 selectively infected cancer cells and spared normal cells as confirmed by immunohistochemistry. Sensitivity of detecting fluorescent green cells was 92% (confidence interval [CI] 83% to 97%) at a ratio of 1 cancer cell to 1 million normal cells. EGFP-positive cells were detected by fluorescent microscopy in patients' malignant pleural effusion samples. Our data show proof of the concept that NV1066-induced EGFP expression allows detection of a single cancer cell against a background of 1 million normal cells. This method was demonstrated to be a reliable screening tool for human cancer cells in a suspension of norma murine cells as well as clinical specimens of malignant pleural effusions.

AB - Cytological analysis of body fluids is currently used for detecting cancer. The objective of this study was to determine if the herpes virus carrying an enhanced green fluorescent protein (EGFP) could detect rare cancer cells in body fluids against millions of normal cells. Human cancer cells suspended with normal murine cells were infected with NV1066 at a multiplicity of infection (MOI) of 0.5 and 1.0 for 18 h. Fluorescent microscopy and flow cytometry were used for EGFP detection of cancer cells. EGFP-expressing cells were confirmed as cancer cells with specific markers by immunohistochemistry staining. Limits of detection of cancer cells in body fluid were measured by serial dilutions. Applicability of technique was confirmed with samples from patients with malignant pleural effusions. NV1066 expressed EGFP in 111 human cancer cell lines detected by fluorescent microscopy at an MOI of 0.5. NV1066 selectively infected cancer cells and spared normal cells as confirmed by immunohistochemistry. Sensitivity of detecting fluorescent green cells was 92% (confidence interval [CI] 83% to 97%) at a ratio of 1 cancer cell to 1 million normal cells. EGFP-positive cells were detected by fluorescent microscopy in patients' malignant pleural effusion samples. Our data show proof of the concept that NV1066-induced EGFP expression allows detection of a single cancer cell against a background of 1 million normal cells. This method was demonstrated to be a reliable screening tool for human cancer cells in a suspension of norma murine cells as well as clinical specimens of malignant pleural effusions.

UR - http://www.scopus.com/inward/record.url?scp=79960715814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960715814&partnerID=8YFLogxK

U2 - 10.2119/molmed.2011.00078

DO - 10.2119/molmed.2011.00078

M3 - Article

C2 - 21487639

AN - SCOPUS:79960715814

VL - 17

SP - 628

EP - 634

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 7-8

ER -